The challenge
- 97% of chronic, non-healing wounds have low oxygen levels or chronic lack of oxygen (hypoxia)
- Additional associated comorbidities will only compromise oxygen supply further
- Chronic hypoxia leads to inactivation of growth factors and cellular senescence, with eventual wound deterioration.
The solution
- Oxygen is essential for wound healing, is required to create energy for cells to function and is essential for immune cells to attack bacteria, thus is pivotal in the host response to tackling infection2,3
- Early intervention with supplemental oxygen to injured tissues, such as topical oxygen therapy (TOT), can help to correct this.
Introducing NATROX® O2
NATROX® O2 is a wearable medical device designed to deliver continuous topical oxygen therapy (cTOT) directly to a wound to support improved healing.
Patients can continue with their normal daily activities as the device is:
- Battery powered/portable
- Discreet and completely silent
- Easy to manage
- Practical for everyday use.
NATROX® O2 is an adjunct to standard of care (SoC), providing oxygen to a wide range of chronic wounds, including:
- Diabetic foot ulcers (DFUs)
- Leg ulcers
- Pressure injuries
- Open surgical wounds.
NATROX® O2 has also been shown to help relieve pain in hard-to-heal leg ulcers, whilst improving healing rates. In a recent study, 76% of patients reported substantial pain relief, which led to 69% discontinuing opioids.
Read to full Quick Guide below
